13F HOLDINGS REPORT
RA CAPITAL MANAGEMENT, L.P.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-062062
Total Value
$7.80B
Positions
75
Other Managers
0
Confidential Omitted
No
Holdings (75)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S - ADR | ASND | 10,108,400 | $1.53B | 19.59% |
| 2 | VAXCYTE INC | PCVX | 8,203,754 | $560.4M | 7.19% |
| 3 | LEGEND BIOTECH CORP-ADR | LEGN | 6,861,097 | $384.8M | 4.93% |
| 4 | JANUX THERAPEUTICS INC | JANX | 9,165,652 | $345.1M | 4.42% |
| 5 | AEROVATE THERAPEUTICS INC | 008064107 | 8,263,982 | $244.4M | 3.13% |
| 6 | RHYTHM PHARMACEUTICALS INC | RYTM | 5,330,412 | $231.0M | 2.96% |
| 7 | EVOLENT HEALTH INC - A | EVH | 5,736,132 | $188.1M | 2.41% |
| 8 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 7,864,000 | $186.0M | 2.38% |
| 9 | RXSIGHT INC | RXST | 3,442,825 | $177.6M | 2.28% |
| 10 | TYRA BIOSCIENCES INC | TYRA | 10,416,609 | $170.8M | 2.19% |
| 11 | EDGEWISE THERAPEUTICS INC | EWTX | 8,909,091 | $162.5M | 2.08% |
| 12 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 5,051,511 | $160.9M | 2.06% |
| 13 | BIOGEN INC | BIIB | 740,727 | $159.7M | 2.05% |
| 14 | PEPGEN INC | PEPG | 10,689,545 | $157.1M | 2.01% |
| 15 | GERON CORP | GERN | 46,202,425 | $152.5M | 1.96% |
| 16 | 89BIO INC | 282559103 | 12,766,948 | $148.6M | 1.91% |
| 17 | DYNE THERAPEUTICS INC | DYN | 4,954,779 | $140.7M | 1.80% |
| 18 | APOGEE THERAPEUTICS INC | APGE | 1,977,901 | $131.4M | 1.69% |
| 19 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 7,809,852 | $129.0M | 1.65% |
| 20 | NKARTA INC | NKTX | 10,805,129 | $116.8M | 1.50% |
| 21 | WAVE LIFE SCIENCES LTD | WVE | 18,202,009 | $112.3M | 1.44% |
| 22 | ARS PHARMACEUTICALS INC | SPRY | 10,860,977 | $111.0M | 1.42% |
| 23 | FULCRUM THERAPEUTICS INC | FULC | 11,609,704 | $109.6M | 1.41% |
| 24 | VERONA PHARMA PLC - ADR | 925050106 | 6,317,990 | $101.7M | 1.30% |
| 25 | LENZ THERAPEUTICS INC | LENZ | 4,178,823 | $93.3M | 1.20% |
| 26 | INHIBRX INC | INBX | 2,629,837 | $91.9M | 1.18% |
| 27 | AVIDITY BIOSCIENCES INC | 05370A108 | 3,282,180 | $83.8M | 1.07% |
| 28 | AXSOME THERAPEUTICS INC | AXSM | 1,000,000 | $79.8M | 1.02% |
| 29 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 3,289,119 | $71.0M | 0.91% |
| 30 | DIANTHUS THERAPEUTICS INC | DNTH | 2,333,000 | $70.0M | 0.90% |
| 31 | GH RESEARCH PLC | GHRS | 6,251,714 | $66.6M | 0.85% |
| 32 | STRUCTURE THERAPEUTICS INC | GPCR | 1,510,362 | $64.7M | 0.83% |
| 33 | MINERALYS THERAPEUTICS INC | MLYS | 4,850,984 | $62.6M | 0.80% |
| 34 | ASTRIA THERAPEUTICS INC | 04635X102 | 4,413,150 | $62.1M | 0.80% |
| 35 | ACUMEN PHARMACEUTICALS INC | ABOS | 14,932,063 | $60.5M | 0.78% |
| 36 | ITEOS THERAPEUTICS INC | 46565G104 | 4,417,259 | $60.3M | 0.77% |
| 37 | SOLID BIOSCIENCES INC | SLDB | 4,330,446 | $57.7M | 0.74% |
| 38 | MADRIGAL PHARMACEUTICALS INC | MDGL | 204,500 | $54.6M | 0.70% |
| 39 | VOR BIOPHARMA INC | VOR | 22,748,880 | $53.9M | 0.69% |
| 40 | PRAXIS PRECISION MEDICINES I | PRAX | 828,380 | $50.5M | 0.65% |
| 41 | UROGEN PHARMA LTD | URGN | 3,083,430 | $46.3M | 0.59% |
| 42 | LARIMAR THERAPEUTICS INC | LRMR | 6,045,351 | $45.9M | 0.59% |
| 43 | CYTEK BIOSCIENCES INC | CTKB | 6,809,404 | $45.7M | 0.59% |
| 44 | C4 THERAPEUTICS INC | CCCC | 4,878,000 | $39.9M | 0.51% |
| 45 | WEREWOLF THERAPEUTICS INC | HOWL | 6,144,881 | $39.8M | 0.51% |
| 46 | ENLIVEN THERAPEUTICS INC | ELVN | 2,122,465 | $37.3M | 0.48% |
| 47 | ELIEM THERAPEUTICS INC | CLYM | 13,150,849 | $36.0M | 0.46% |
| 48 | ACRIVON THERAPEUTICS INC | ACRV | 4,810,508 | $34.4M | 0.44% |
| 49 | TAYSHA GENE THERAPIES INC | TSHA | 10,872,503 | $31.2M | 0.40% |
| 50 | BOUNDLESS BIO INC | BOLD | 2,180,631 | $31.1M | 0.40% |
| 51 | MACROGENICS INC | MGNX | 2,082,021 | $30.6M | 0.39% |
| 52 | TENAYA THERAPEUTICS INC | TNYA | 5,755,050 | $30.1M | 0.39% |
| 53 | CYBIN INC | HELP | 58,139,535 | $24.0M | 0.31% |
| 54 | ALTO NEUROSCIENCE INC | ANRO | 1,385,491 | $21.3M | 0.27% |
| 55 | CERVOMED INC | CRVO | 861,573 | $20.1M | 0.26% |
| 56 | VAXART INC | VXRT | 15,384,615 | $20.0M | 0.26% |
| 57 | BICYCLE THERAPEUTICS PLC-ADR | BCYC | 800,000 | $19.9M | 0.26% |
| 58 | EYEPOINT PHARMACEUTICALS INC | EYPT | 938,591 | $19.4M | 0.25% |
| 59 | THIRD HARMONIC BIO INC | 88427A107 | 2,033,056 | $19.2M | 0.25% |
| 60 | PLIANT THERAPEUTICS INC | PLRX | 1,281,000 | $19.1M | 0.24% |
| 61 | SERA PROGNOSTICS INC-A | SERA | 2,024,221 | $18.4M | 0.24% |
| 62 | METAGENOMI INC | MGX | 1,744,415 | $18.4M | 0.24% |
| 63 | IMMATICS NV | IMTX | 1,750,000 | $18.4M | 0.24% |
| 64 | AN2 THERAPEUTICS INC | ANTX | 5,551,295 | $18.0M | 0.23% |
| 65 | REGULUS THERAPEUTICS INC | 75915K309 | 6,250,000 | $18.0M | 0.23% |
| 66 | BLACK DIAMOND THERAPEUTICS I | BDTX | 3,525,754 | $17.9M | 0.23% |
| 67 | ADICET BIO INC | ACET | 7,541,000 | $17.7M | 0.23% |
| 68 | ARVINAS INC | ARVN | 421,348 | $17.4M | 0.22% |
| 69 | LEXEO THERAPEUTICS INC | LXEO | 660,938 | $10.4M | 0.13% |
| 70 | CHIMERIX INC | 16934W106 | 8,800,000 | $9.3M | 0.12% |
| 71 | IGM BIOSCIENCES INC | 449585108 | 937,500 | $9.0M | 0.12% |
| 72 | COMPASS PATHWAYS PLC | CMPS | 791,359 | $6.6M | 0.08% |
| 73 | CUREVAC NV | N2451R105 | 1,965,707 | $6.0M | 0.08% |
| 74 | UNICYCIVE THERAPEUTICS INC | UNCY | 3,470,688 | $4.8M | 0.06% |
| 75 | NEWAMSTERDAM PHARMA CO NV-27 | NAMSW | 333,333 | $3.7M | 0.05% |